UK pharma major GSK yesterday announced that the US Food and Drug Administration (FDA) has approved Exdensur ...

USA and Europe listed biotech PureTech has appointed Robert Lyne as chief executive (CEO), and as a member of the board of ...

US biotech Incyte yesterday revealed that the European Commission (EC) has approved Minjuvi (tafasitamab) in combination with ...

Switzerland-based Topadur Pharma, a biotech company developing innovative therapies for vascular regeneration, has announced ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a new indication for Dutch immunology company ...

US venture firm MBX Capital has crossed $100 million in cumulative capital commitments to invest in early-stage biotech and ...

German biotech T-CURX today announced the first closing of a $20 million (17.7 million) Series A financing with a syndicate ...

US clinical-stage oncology company NanOlogy has appointed David Arthur as chief executive, as it accelerates development of ...

A wave of transformative US drug-pricing agreements and record manufacturing investments from leading biopharmaceutical ...

US drug distribution and services group Cencora (NYSE: COR) said it has agreed to accelerate its acquisition of a controlling ...

Canadian biotech Oncolytics Biotech (Nasdaq: ONCY) has reported encouraging clinical and translational data for its oncolytic ...

Across major agencies, the past fortnight brought a steady cadence of regulatory decisions, committee opinions, and ...